BioAtla (BCAB) Operating Expenses (2020 - 2026)

BioAtla (BCAB) has reported Operating Expenses for 7 consecutive years, with $6.3 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Operating Expenses fell 66.36% year-over-year to $6.3 million; the trailing twelve-month figure through Jun 2026 stood at $40.6 million (down 45.67% YoY), and the FY2025 full-year result was $61.3 million, down 27.83% from the prior year.
• Operating Expenses fell to $6.3 million in Q2 2026 per BCAB's latest filing, from $9.3 million in the prior quarter.
• Across five years, Operating Expenses topped out at $37.2 million in Q2 2023 and bottomed at $6.3 million in Q2 2026.
• Historically, Operating Expenses has averaged $22.2 million across 5 years, with a median of $23.3 million in 2022.
• The sharpest annual moves came in 2023 and 2026: Operating Expenses soared 33.77% in 2023, then plunged 66.36% in 2026.
• Over 5 years, Operating Expenses stood at $28.6 million in 2022, then dropped by 0.08% to $28.5 million in 2023, then slumped by 43.08% to $16.2 million in 2024, then tumbled by 30.71% to $11.3 million in 2025, then tumbled by 44.26% to $6.3 million in 2026.
• According to Business Quant data, Operating Expenses over the past three periods registered $6.3 million, $9.3 million, and $11.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.